News & Updates
This box produces 3000 kg of world-class Australian beef1...
Compudose is proven to maximise growth rates in grassfed cattle. The average of 134 trials conducted in Australia shows cattle implanted with Compudose have a 15.8 percent average weight gain advantage compared to non-implanted cattle.1 This means a single box of Compudose 400 can increase your production of world-class Australian beef by 3000 kg.2
... and helps you to achieve market specifications sooner.
Compudose 400 helps your cattle to reach target market specifications, sooner. As Compudose 400 has a payout period of 400 days, you can implant when it suits you and have your cattle ready for turn-off when required. This gives you maximum flexibility with stocking rates, paddock rotations and supplementary feeding.
This box produces about $10,000 of world-class Australian beef1...
Compudose delivers you more profit, more consistently. In fact, a single box of Compudose can increase your profitability by about $10,000.2 An independent economic study found that the additional weight gain advantage provided by implants routinely deliver higher returns than implant-free cattle, even when market premiums are considered.3
…. and is your passport to most major export and domestic markets.
Compudose allows you to target and achieve specifications for most major export and domestic markets for world class Australian boxed beef, including MSA-graded markets.4 Major export markets for Australian boxed beef, including Japan, Korea, Taiwan, USA and Canada, accept cattle treated with implants. Likewise, most domestic markets and feedlots also accept implanted cattle, giving you the flexibility to turn off cattle sooner.
This box is helping to deliver about $172 million to Australian beef producers each year4...
Implants have been widely used to improve growth rates and feed conversion efficiency in the Australian beef industry for more than 30 years. An economic analysis conducted in 2014 shows the use of implants helps to produce about 150,000 more tonnes of world-class Australian beef each year.5 The use of growth enhancing technologies, such as Compudose and Rumensin™, provide important environmental benefits by maximising productivity from available resources and reducing greenhouse gas emissions.7,8,9
Choosing the right box of Compudose
Selecting the right implant
Elanco markets a complete range of long, medium and short acting implants suitable for maximising growth rates in grassfed cattle. The performance and recommended usage of each implant depends upon its active ingredient(s), formulation and length of payout. Your Elanco representative can provide advice about which implants and implant strategies are best for your situation.
Compudose 400, 200 and 100
Compudose 400, 200 and 100 contain oestradiol-17ß, a naturally-occurring oestrogen. Each formulation consists of an inert silicone rubber core covered with a coating of oestradiol-medicated silicone rubber. The durable core helps in preventing crushing or breaking during implantation, ensuring consistent pay out and long-term performance. The active ingredient is slowly released into the bloodstream to provide a daily dose above the threshold for growth promotion over 400, 200 or
100 days, respectively.
Compudose-G
Compudose-G contains oestradiol and trenbolone acetate (TBA), a synthetic androgen. Compudose-G consists of three compressed pellets using a cholesterol carrier that are quickly absorbed into the bloodstream after implantation. Compudose-G is a short-acting implant that has a minimum re-implanting interval of 70 days. For best results, Compudose-G should only be used under very good nutritional conditions and ideally, as a terminal implant.
Elanco Data on File (2000) Australian Compudose Trials in Bos Taurus Cattle – Summary of Trials. 2. Figures assume a 15.8% liveweight gain advantage in cattle gaining 0.5 kg/day over 400 days, $3.17/kg liveweight and 100 implants per box. Results may vary according to seasonal and market conditions. 3. Kreitals Consulting Group (2010) Beef producer returns from supplying Japanese or EU markets. 4. Meat and Livestock Australia, Meat Standards Australia data on file. 5. Assessment of benefits from using HGPs, Fresh Agenda (2014). 6. Baron Audit Data MAT Dec 2013). 7. McCrabb, G.J. & Hunter, R.A. 2002. Lifetime methane production is reduced when beef cattle are repeatedly treated with an hormonal growth promotant. Proceedings of Australian Society of Animal Production. pp. 327. 8. Capper, J.L. & Hayes, D.J. (2012). The environmental and economic impact of removing growth enhancing technologies from U.S. beef production. Journal of Animal Science, 90(10):3527-37. 9. Capper, J.L. (2011). The environmental impact of beef production in the United States: 1977 compared with 2007. Journal of Animal Science, 89(12): 4249-61. ^Image for display purposes only. Please read and follow the instructions on the approved Compudose 400 label. Always refer to the registered label directions before use. Elanco, Compudose™, Component™ and Rumensin™ and the diagonal bar are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates. ©2018 Elanco Australasia Pty Ltd (ABN 64076745198), a wholly-owned subsidiary of Eli Lilly & Company. EAH18117 AUCTLCPD00076